Table 5 Treatment effect of dialysate to serum sodium alignment on volume-related and hemodynamic parameters in those patients part to this quality initiative (intention-to-treat cohort; N = 163) and the propensity score matched control cohort (N = 163)
Parameter | Study Regimen | Baseline | Follow-up | Difference (95% CI) | Treatment effect (95% CI) |
|---|---|---|---|---|---|
IDWG [L] | aligned | 2.53+/−0.93 | 2.42+/−0.83 | −0.11 (−0.3 to 0.08) | −0.12 (−0.24 to 0) |
unaligned | 2.67+/−0.97 | 2.7+/−1 | 0.01 (−0.2 to 0.22) | ||
UFV [L] | aligned | 2.44+/−0.86 | 2.32+/−0.76 | −0.12 (−0.3 to 0.06) | −0.15 (−0.25 to −0.04) |
unaligned | 2.58+/−0.96 | 2.6+/−0.9 | 0.03 (−0.18 to 0.23) | ||
Pre HD weight [kg] | aligned | 81.82+/−22.63 | 81.21+/−22.13 | −0.61 (−5.48 to 4.27) | −0.34 (−1.08 to 0.39) |
unaligned | 80+/−21.44 | 79.7+/−20.9 | −0.26 (−4.88 to 4.36) | ||
Post HD weight [kg] | aligned | 79.41+/−22.18 | 78.81+/−21.47 | −0.6 (−5.35 to 4.16) | −0.29 (−1.01 to 0.43) |
unaligned | 77.44+/−20.96 | 77.1+/−20.4 | −0.31 (−4.82 to 4.2) |